Tokyo Tape
Sign in

Sumitomo Pharma

4506.TPharmaceutical
Key numbers · FY ended 2026-03
Revenue¥453.3bn+13.7% YoYOperating income¥107.3bn+272.6% YoYNet income (owners)¥106.9bn+352.2% YoYTotal assets¥804.6bn+8.3% YoYEPS (basic)¥268.99+352.2% YoY

Full financial history and reports →

Stock price4506 · View chart ↗

Open the price chart on TradingView.

Latest filings
Wed, Sep 2 · JST1 filing
14:49MATERIALSumitomo Pharma · Event with a material impact on financial position
Wed, Mar 25 · JST1 filing
15:43MATERIALSumitomo Pharma · Event with a material impact on financial position
Fri, Oct 31 · JST1 filing
16:45MATERIALSumitomo Pharma · Change in parent company or specified subsidiary
Fri, Aug 29 · JST1 filing
15:35MATERIALSumitomo Pharma · Change in parent company or specified subsidiary
Mon, Apr 28 · JST1 filing
17:03MATERIALSumitomo Pharma · Event with a material impact on financial position

All filings →

Major holders (5%+) · 1
HolderStakeChangeFiled
SUMITOMO CHEMICAL COMPANY, LIMITED51.68%—2026-04-23

Each holder's own ratio from its most recent large-shareholding report.